At the news
? NEUTRALIMPACT 2/10 144 filed Nov 12, 2026 at 16:23 ET
Kendra Adams, an officer of C4 Therapeutics, filed a Form 144 notice of intent to sell 45,173 shares of common stock, with an approximate market value of $122,487 based on the filing. The shares were acquired upon vesting of restricted stock and performance shares between May 2022 and February 2026. The sale is scheduled for November 12, 2026.
- Reporting owner: Kendra Adams, an officer of C4 Therapeutics
- Shares to be sold: 45,173 shares of common stock
- Estimated value: $122,486.59 (based on approximate market price of $2.71 per share)
- Shares acquired upon vesting of restricted stock and performance shares from May 2022 to February 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access